Literature DB >> 9802936

Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.

A Bakri Hassan1, J Rönnelid, I Gunnarsson, G Karlsson, L Berg, I Lundberg.   

Abstract

It is controversial whether mixed connective tissue disease (MCTD) should be regarded as a distinct disease entity. In the present study, we investigated immunological parameters in patients with MCTD by studying serum levels of immunoglobulins, C-reactive protein (CRP) and cytokines and compared the results to the corresponding values in systemic lupus erythematosus (SLE), in rheumatoid arthritis (RA) patients and in healthy controls. Using the ELISA technique, serum levels of the cytokines interferon-gamma (IFN-gamma), interleukin-10 (IL-10) and tumour necrosis factor-alpha (TNF-alpha) were investigated. Cytokine levels in SLE and MCTD were correlated to disease activity as assessed by systemic lupus activity measure (SLAM). They were also correlated to serum levels of CRP, IgG, IgA and IgM in the three patient groups. The MCTD patients had the highest levels of immunoglobulins, followed by the SLE patients. In contrast, the highest CRP levels were observed in RA patients, followed by the MCTD patients. The MCTD patients had the highest serum levels of IL-10, but also had elevated IFN-gamma and TNF-alpha levels similar to the RA patients. There was no correlation between the investigated cytokine levels and disease activity, as assessed by SLAM. We conclude that MCTD patients have high immunoglobulin levels as well as high CRP levels and that this situation is compatible with the observed increase in both type 1 and type 2 cytokine levels. The findings imply that MCTD shares some distinct immunological properties with both RA and SLE and that MCTD may also be considered as a separate disease entity according to these properties. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802936     DOI: 10.1006/jaut.1998.0236

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  9 in total

Review 1.  Autoantibodies and overlap syndromes in autoimmune rheumatic disease.

Authors:  E C Jury; D D'Cruz; W J Morrow
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

2.  IgM colocalises with complement and C reactive protein in infarcted human myocardium.

Authors:  P A J Krijnen; C Ciurana; T Cramer; T Hazes; C J L M Meijer; C A Visser; H W M Niessen; C E Hack
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

3.  Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

Authors:  M F Carpintero; L Martinez; I Fernandez; A C Garza Romero; C Mejia; Y J Zang; R W Hoffman; E L Greidinger
Journal:  Lupus       Date:  2015-03-02       Impact factor: 2.911

4.  Relationship of circulating total homocysteine and C-reactive protein to trabecular bone in postmenopausal women.

Authors:  Shilpa N Bhupathiraju; D Lee Alekel; Jeanne W Stewart; Laura N Hanson; Kristine M Shedd; Manju B Reddy; Kathy B Hanson; Marta D Van Loan; Ulrike Genschel; Kenneth J Koehler
Journal:  J Clin Densitom       Date:  2007-07-26       Impact factor: 2.617

Review 5.  Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis.

Authors:  Yulei Hao; Meiying Xin; Shuang Wang; Di Ma; Jiachun Feng
Journal:  Neurol Sci       Date:  2019-05-21       Impact factor: 3.830

6.  Identification of a truncated splice variant of IL-18 receptor alpha in the human and rat, with evidence of wider evolutionary conservation.

Authors:  Chris S Booker; David R Grattan
Journal:  PeerJ       Date:  2014-09-11       Impact factor: 2.984

Review 7.  U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasePart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease.

Authors:  Agnieszka Paradowska-Gorycka
Journal:  Reumatologia       Date:  2015-08-07

Review 8.  U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue diseasePart I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease.

Authors:  Agnieszka Paradowska-Gorycka
Journal:  Reumatologia       Date:  2015-05-18

9.  Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.

Authors:  Venkat Reddy; Lina Martinez; David A Isenberg; Maria J Leandro; Geraldine Cambridge
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-24       Impact factor: 4.794

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.